What is a multidisciplinary tumor board and should my Non-Small Cell Lung Cancer case be presented

Understanding Multidisciplinary Tumor Boards for NSCLC

What Is a Multidisciplinary Tumor Board?

A multidisciplinary tumor board (often called a "tumor board" or "cancer conference") is a team meeting where different cancer specialists come together to review and discuss individual patient cases. Think of it as a "second opinion by committee"—multiple experts examine your medical information and collaborate to develop the best treatment plan for YOUR specific situation.

Who's on the Team?

For Non-Small Cell Lung Cancer, the typical tumor board includes:

• Thoracic surgeons (lung surgery specialists)
• Medical oncologists (chemotherapy and systemic therapy specialists)
• Radiation oncologists (radiation therapy specialists)
• Pulmonologists (lung disease specialists)
• Pathologists (tissue analysis experts)
• Radiologists (imaging interpretation specialists)
• Nurses and other support staff

These specialists bring different expertise to the table, which helps ensure your case is evaluated from every angle.

---

Should YOUR NSCLC Case Be Presented?

Yes—strongly recommended. According to the NCCN Guidelines for Non-Small Cell Lung Cancer, multidisciplinary evaluation is particularly important for NSCLC patients because:

"The diagnostic strategy needs to be decided in a multidisciplinary setting. Decisions about whether a biopsy (including what type of biopsy) or surgical excision is appropriate depend on several factors...which were revised by the NCCN Panel for the 2023 update."

When Tumor Board Review Is Especially Important:

✅ Early-stage disease (Stage I-II) - To determine if surgery, radiation, or combination therapy is best

✅ Locally advanced disease (Stage III) - To coordinate complex treatment combining surgery, chemotherapy, and/or radiation

✅ Metastatic disease (Stage IV) - To evaluate systemic therapy options and whether targeted therapy or immunotherapy applies to your specific tumor

✅ Complex cases - When your tumor has unusual features, multiple nodules, or when treatment decisions are unclear

✅ Before major surgery - The NCCN Guidelines emphasize: "Thoracic surgical oncology consultation should be part of the evaluation of any patient being considered for curative local therapy"

---

Why This Matters for Your Care

According to NCCN Guidelines, multidisciplinary review helps ensure:

1. Accurate staging - All specialists confirm the extent of your cancer
2. Optimal treatment selection - Different experts identify the best approach for YOUR specific situation
3. Coordination of care - If you need surgery AND chemotherapy AND radiation, the team coordinates timing and sequencing
4. Biomarker testing decisions - The team determines what genetic/molecular tests you need (EGFR mutations, PD-L1 expression, etc.) to guide targeted therapy options
5. Avoiding treatment delays - The NCCN Guidelines specifically note: "Treatment delays, because of poor coordination among specialists, should be avoided"

---

Questions to Ask Your Healthcare Team

1. "Has my case been presented to a multidisciplinary tumor board?" If not, ask if it can be.

2. "Who are the specialists involved in my care, and how do they communicate with each other?"

3. "What testing do you recommend for my tumor, and why?" (This helps ensure you get appropriate biomarker testing)

4. "What are the treatment options being considered, and what are the pros and cons of each?"

5. "If I need multiple treatments (like surgery plus chemotherapy), how will the timing work?"

---

How to Request Tumor Board Review

• Ask your oncologist or surgeon directly: "Can my case be reviewed by the multidisciplinary tumor board?"
• Most major cancer centers and teaching hospitals have formal tumor boards that meet regularly
• If your current facility doesn't have one, ask about referral to a center that does
• Many patients benefit from getting a second opinion at a comprehensive cancer center

---

Bottom Line

The NCCN Guidelines emphasize that multidisciplinary evaluation is standard of care for NSCLC patients, especially those with stage IB disease or higher, or those with complex presentations. This collaborative approach significantly improves treatment planning and coordination.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.